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Dr Dossdoi:10.1016/j.jtcvs.2004.09.034Objective: High mortality and paraplegia rates associated with the surgical man-
agement of acute thoracic aortic ruptures limit its success. It was our objective to
evaluate whether emergency endovascular interventions would improve the out-
comes of these patients.
Methods: Sixty patients aged 28 to 83 years were admitted to our institution with an
acute rupture of the thoracic aorta (27 ruptured aneurysms, 15 perforated type B
dissections, 18 traumatic ruptures). Twenty-eight patients were treated surgically
with cardiopulmonary bypass, and 32 patients were acutely treated with an endo-
vascular stent graft. Medical records were reviewed for prehospital and emergency
department data, operative findings, and outcomes. Patients were followed up at
yearly intervals with high-resolution multidetector computed tomographic angiog-
raphy.
Results: Perioperatively, there were 1 death (3.1%) among the 32 patients in the
endovascular group and 5 deaths (17.8%) among the 28 patients in the surgical
group. There were 4 late deaths in the endovascular group and 1 in the surgical
group. There were 2 access failures in the endovascular group. There were 1 stroke
in the endovascular group and 1 case of paraplegia in the surgical group. Three
patients in the endovascular group had endovascular leaks develop that required
reintervention. Two patients in the endovascular group had late thrombosis of the
left subclavian artery.
Conclusion: Despite encouraging early outcomes, midterm results suggest a trend
toward increased reintervention and late complication rates in the endovascular
group. Therefore continued surveillance of patients treated with stent grafts is
necessary.
Advantages of endovascular treatment relative to conventional sur-gical management of acute thoracic aortic rupture include reducedperioperative mortality and morbidity rates. Emergency endovas-cular intervention may be of particular benefit for patients ofadvanced age with severe comorbidities. In our single-centerexperience, we reported superior early outcomes for less invasive
endovascular approach relative to a concurrent control group treated by conven-
tional open surgery.1 However, intermediate- and long-term results of emergency
endovascular interventions are scarce, and no comparative studies are reported in the
literature. This study was primarily undertaken to assess the intermediate-term
results of emergency repair of acute thoracic aortic ruptures and compare outcomes
of the endovascular approach with those of conventional open surgical management.
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In our practice, we define acute thoracic aortic rupture as follows:
recent onset of thoracic pain, evidence of leakage from the aorta,
periaortic hematoma, and left-sided hemothorax. Between Novem-
ber 1999 and May 2002, a total of 60 consecutive patients with
acute rupture of the thoracic aorta were admitted to our institution.
Thirty-two of these patients were acutely treated with an endovas-
cular stent graft, and 28 patients were treated with conventional
open surgical graft interposition under cardiopulmonary bypass.
Overall, 27 ruptured descending thoracic aortic aneurysms, 15
perforated type B dissections, and 18 traumatic ruptures of the
descending aorta were treated.
Patient Allocation and Group Comparability
Within the period mentioned, all patients with an acute rupture of
the thoracic aorta were included in the study. Patients were allo-
cated to either surgical or endovascular treatment in a nonrandom-
ized fashion. Table 1 lists the preoperative demographic and clin-
ical data of all patients. All admitted patients with acute lesions of
the descending thoracic aorta were primarily considered as poten-
tial candidates for endovascular stent-graft placement. Lesions
involving the aortic arch or originating from the ascending aorta,
a heavy torturous course of the thoracic aorta, and a diameter of the
common iliac arteries of less than 7 mm excluded the patient from
endovascular stent-graft deployment.
A prerequisite for stent-graft placement was landing zone di-
ameter of less than 44 mm. This is because of a lack of commer-
cially available stent grafts of larger sizes and the fact that we tend
to oversize by 3 to 5 mm. Another prerequisite was landing zone
length of 1.5 cm or greater to the celiac axis and the left common
carotid artery, because in an emergency setting we would routinely
sacrifice the left subclavian artery. Concomitant diseases, render-
TABLE 1. Preoperative demographic and clinical data
Characteristic
Endovascular
(n  32)
Open
(n  28)
Age (y, mean  SD) 61.3  17.1 68.7  21.3
Male (No.) 17 18
Female (No.) 15 10
Previous thoracic surgery (No.) 3 5
Multiple traumatic injuries (No.) 3 4
Hypertension (No.) 14 10
Chronic obstructive pulmonary
disease (No.)
9 2
Traumatic brain injury (No.) 1 0
Cardiac disease (No.) 7 2
Renal failure (No.) 2 1
Hepatic disease (No.) 2 1
Marfan disease (No.) 1 0
Ruptured thoracic aortic
aneurysm (No.)
15 11
Perforated type B dissection
(No.)
10 5
Traumatic rupture (No.) 7 12ing patients high-risk surgical candidates, were chronic obstructive
646 The Journal of Thoracic and Cardiovascular Surgery ● Marpulmonary disease, recent stroke, cardiac disease, renal failure,
and hepatic disease.
Preoperative Work-up
All patients included in this study underwent the same diagnostic
and resuscitation protocol. On admission, high-resolution multide-
tector computed tomographic angiography from the thorax to the
groins was used to determine the size and type of the aortic lesions
(ie, dissection, aneurysm, transection), to assess the potential land-
ing zones, to allow calculation of stent-graft sizes, and to assess the
caliber of the access vessels. Stent grafts either were available off
the shelf or were delivered within 4 hours on request.
Our resuscitation protocol was the same for both the surgical
and the endovascular groups. Depending on clinical status at
admission to the hospital, most patients required some form of
immediate medical attention to stabilize their hemodynamic con-
dition and allow the planning of an endovascular or surgical
procedure. All patients were thus monitored in the intensive or
intermediate care ward.
To proceed with an endovascular procedure, patients had to
respond to our resuscitation therapy, fulfilling the following crite-
ria: systolic blood pressure 90 to 120 mm Hg, heart rate less than
110 beats/min, central venous pressure 7 to 14 cm H2O, and
hemoglobin greater than 10 g/dL. Most patients presented in a state
of shock and needed either inotropic resuscitation with dopamine
or norepinephrine in moderate dosages or volume resuscitation
with colloids and blood products. Overall, 27 patients needed
opioids to treat acute back or chest pain. Five patients were
severely hypertensive on admission, with systolic blood pressures
as great as 200 mm Hg. To control this hypertension, -blockers,
-blockers, and nitrates were used.
Stent-Graft Placement
Our technique of stent-graft placement has been described else-
where. In short, two different commercially available thoracic
stent-graft systems were implanted in this study, Talent LPS
(Medtronic World Medical, Sunrise, Fla) and Excluder (W.L. Gore
& Associates, Inc, Sunnyvale, Calif). After successful surgical
exposure of the femoral artery and transverse arteriotomy, a pigtail
catheter was positioned in the ascending thoracic aorta over a soft,
angled guidewire (Radiofocus standard guidewire M; Terumo,
Tokyo, Japan). The guidewire was exchanged to a super-stiff
guidewire (Lunderquist extra stiff; Cook Inc, Bloomington, Ind)
for stent-graft insertion. After an initial, angulated digital subtrac-
tion angiography of the thoracic aorta with 30 mL contrast material
(Visipaque 320; Nycomed Amersham, Buchler, Germany) and a
flow rate of 15 mL/s, 5000 IU heparin was administered intra-
arterially. The stent-graft system was then advanced into the de-
sired position, and correct location was verified by an additional
digital subtraction angiography immediately before stent-graft de-
ployment. To avoid downstream migration of the device during
deployment, systolic arterial blood pressure was lowered to 70 mm
Hg with sodium nitroprusside just before device release or short
cardiac arrest was achieved by intravenous injection of adenosine
(6-12 mg) to ease device deployment and allow exact device
positioning at the orifice of the left subclavian or carotid artery. In
all cases, postdilation was performed with an endoballoon to
obtain optimal shape and sealing of the implanted stent graft.
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verify appropriate stent-graft location and to demonstrate free
perfusion of the supra-aortic vessels as well as the stent graft.
All interventional materials were removed, and the arteriotomy
was closed with a continuous 5.0 Prolene suture (Ethicon, Inc,
Somerville, NJ). All patients were transferred to the intensive
care unit for postoperative surveillance for at least 4 hours. All
patients had a single-shot, broad-spectrum antibiotic prophy-
laxis (third-generation cephalosporins) just before the initial
incision. Follow-up examinations were performed with multi-
detector computed tomographic angiographic scans before dis-
charge and at 3, 6, and 12 months after implantation.
Surgical Technique
After transfer to the operating room, double-lumen endotracheal
intubation and routine hemodynamic monitoring were performed.
For spinal cord protection, cerebral spinal fluid drainage was used
in 20 patients (71.4%). Before establishment of femorofemoral
bypass, all patients had systemic heparinization. Access to the
descending thoracic aorta was gained through a left posterolateral
thoracotomy incision, through the fifth intercostal space. The left
lung was then collapsed, and the aorta proximal and distal to the
diseased segment was dissected and isolated circumferentially.
Profound hypothermia of 18°C was induced in all patients. The
proximal anastomosis was performed between clamps. After tran-
section of the aorta, the proximal anastomosis was made first with
a collagen-impregnated Dacron polyester fabric tube graft. Small
segmental intercostal arteries were oversewn, and large ones were
reattached to the graft. Circulation to the lower extremities, kid-
neys, and viscera was provided by distal aortic perfusion. Just
before completion of the distal anastomosis, the distal clamp was
opened, arterial perfusion was reestablished through the femoral
artery, and the graft was deaired. Rewarming was then initiated
after adequate hemostasis, and femorofemoral bypass was discon-
tinued. After successful weaning from bypass, the heparin was
reversed with protamine sulfate.
Follow-up
Perioperative outcomes were evaluated by reviewing all medical
records for prehospital and emergency department data, operative
and interventional findings, and outcomes. After discharge, all
patients treated with endovascular stent grafts were followed up in
our hospital with high-resolution multidetector computed tomo-
graphic angiography at 6 months and at yearly intervals thereafter.
Follow-up was complete for all patients. Follow-up for open
surgery was obtained by contacting the respective general practi-
tioners and patients or family members 1 year postoperatively and
between October and December 2003. Follow-up was also com-
plete for this group of patients. Postoperative complications and
mortality were determined by acquiring autopsy reports or medical
records and hospital discharge letters.
Results
The mean follow-up was 36.4  12.8 months (maximum
follow-up 50 months). The overall perioperative mortality
was 10%. There was 1 early death in the endovascular group
The Journal of Thoraci(3.1%), that of a patient with a ruptured thoracic aortic
aneurysm. Perioperative hemodynamic stabilization of this
patient was not entirely possible, and although a steady state
was achieved, the patient remained in tachycardia (heart rate
110 beats/min) and hypotensive (blood pressure 90/60 mm
Hg). On induction of general anesthesia, the patient went
into left ventricular failure and died before access for stent-
graft placement was established.
In the surgical group, causes of early death were low-
output syndrome in 2 patients, sepsis in 1, and intraopera-
tive hypovolemia in 2. No further deaths occurred in either
group within the first 12 postoperative months. There were
4 additional deaths in the endovascular group (15.6%) at 14,
36, 40, and 44 postoperative months. Three were stent-graft
related (1 aneurysm, 1 dissection, and 1 traumatic transec-
tion). The landing zones were within 2 cm of undiseased
aorta in the patients with aneurysm and traumatic transec-
tion and covering the intimal tear in the patients with
dissection. In none of these patients was severe angulation
of the aorta present. The cause of death was late aortic
rupture in 2 cases, as confirmed by autopsy. One of these
patients had angiographic evidence of a proximal endovas-
cular leak at 36 postoperative months, as diagnosed at his
local hospital. Only hours after admission, he had massive
hemoptysis and died while in the ward. The second patient
collapsed and died while getting on a train to visit relatives.
At autopsy, rupture of the descending thoracic aorta with
massive hemothorax was diagnosed. The third patient died
at 44 postoperative months of sudden cardiac death, as
revealed by the medical records of his general practitioner.
To avoid underestimation of stent-graft–related complica-
tions, we considered this death to be procedure related. The
fourth patient had a long-standing history of plasmacytoma
and died of this concomitant illness 14 months after stent-
graft placement. This death was not stent-graft related. In
the surgical group, there was only 1 late death; this was due
to a non–procedure-related cause. An 81-year-old woman
Figure 1. Explanted Talent stent-graft prosthesis 33 months after
being deployed.had pneumonia and died 28 months after surgery.
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In the surgical group, 3 patients (10.7%) required early
reexploration for bleeding. In the endovascular group, 1
patient was reexplored surgically early after the interven-
tion. A large, left-sided hemothorax had not been drained
during the procedure, and empyema subsequently devel-
oped. During reexploration, as the empyema was removed,
sudden bleeding occurred as one of the bare springs pro-
truded through the aneurysmal sack. The bleeding was
successfully oversewn with pledgeted 4-0 Prolene sutures.
There was one perioperative case of paraplegia (1.9%) in
the surgical group and none in the endovascular group.
Paraplegia this patient became evident when the patient was
awakening from anesthesia, despite the presence of a cere-
brospinal fluid drain. At 24 postoperative months, 1 patient
in the endovascular group showed evidence of a distal
endovascular leak, which was treated by deployment of a
second stent graft. This patient had paraplegia develop on
the second postoperative day. A cerebrospinal drain was
placed immediately, but the paraplegia was not reversible.
Figure 2. Actuarial time-related mortalities for en
TABLE 2. Postoperative outcomes of 60 patients with acu
Characteristic
Early
Stent Surgery
Mortality 3.1% 17.8%
Procedure-related death 3.1% 17.8%
Paraplegia 0% 3.6%
Stroke 3.1% 0%
Endovascular leak 6.2% —
Access failure 6.2% —
Reintervention 3.1% 10.7%
Reintervention also included reexploration for bleeding and conversion toIn the endovascular group, there was 1 case of perioperative
648 The Journal of Thoracic and Cardiovascular Surgery ● Martraumatic brain injury in a patient with a traumatic rupture
of the descending thoracic aorta. This patient had been in a
road traffic accident and had multiple injuries, including his
cranium. On admission he was already intubated, so we do
not know his neurologic status before the intervention.
Perioperatively, there were two distal type 1 endovascu-
lar leaks (6.2%) that were diagnosed at discharge from the
hospital. After 6 months, both endovascular leaks had
sealed spontaneously, without the need for further interven-
tion. At late follow-up (24, 33, and 36 postoperative
months), another 3 patients had type 1 endovascular leaks.
Two patients had proximal leaks and 1 had a distal leak.
One patient with a proximal endovascular leak 33 months
after intervention had conversion to open surgery. No fur-
ther endovascular intervention was possible. The stent graft
was removed (Figure 1) through a left-sided thoracotomy,
and the interposition of a Dacron polyester fabric tube graft
carried out. Reintervention was not possible, because the
left subclavian artery had already been overstented at the
initial intervention. The courses of the 2 other patients with
scular and surgical treatment. cum., Cumulative.
pture of the descending thoracic aorta
Late Total
Stent Surgery Stent Surgery
12.5% 3.6% 15.6% 21.4%
9.4% 0% 12.5% 17.8%
3.1% 0% 3.1% 3.6%
0% 0% 3.1% 0%
9.4% — 15.6% —
0% — 6.2% —
6.2% 0% 9.3% 10.7%
surgery.te rulate endovascular leaks have already been described.
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failure (6.2%) caused by small caliber of the iliac vessels.
One of these patients died during the procedure. The second
patient, with a perforated type B dissection, was stabilized
and discharged from the hospital on medical therapy. Her
old age (82 years) and severe concomitant diseases (chronic
obstructive pulmonary disease, hypertension, chronic renal
failure) rendered her a high-risk candidate for open surgery.
Eighteen months after discharge, the patient died at home.
An autopsy was not performed.
Two patients in the endovascular group had late throm-
bosis of the left subclavian artery. In both patients, the left
subclavian artery had been overstented during the initial
intervention.
A summary of all postoperative outcomes is provided in
Table 2.
Discussion
The treatment of acute lesions of the descending thoracic
aorta in an emergency setting remains a great challenge.
Despite widespread use of standardized treatment protocols,
high perioperative morbidity and mortality limit the success
of the conventional open surgical approach.2,3 Associated
severe comorbidity is common in this group of patients and
significantly influences the early outcome. This is illustrated
by Crawford and colleagues,4 who reported a 30-day mor-
tality for ruptured aneurysms of the descending thoracic
aorta in low-risk patients of 12% but a mortality of 44% in
patients with severe medical comorbidities. Debilitating
postoperative morbidity such as paraplegia after emergency
surgery on the thoracic aorta continues to occur at a rate of
2.9% to 25%.2,3,5,6 High rates of respiratory insufficiency,
renal failure, and the need for reexploration for bleeding are
also common after the conventional surgical approach.7,8
In an effort to improve the perioperative outcomes of
patients, endovascular stent grafting of the thoracic aorta
was introduced in the early 1990s.9,10 Safety and technical
feasibility of this approach were soon established and im-
proved, as demonstrated by short-term results for both the
elective and emergency settings.11-13
Although perioperative and short-term results of endo-
vascular stent grafting of the thoracic aorta were encourag-
ing, few midterm and long-term follow up data are avail-
able. The first report of patients with complete 7-year
follow-up was published by Alric and colleagues.14 They
found that for the repair of abdominal aortic aneurysms,
despite acceptable short-term results, stent grafts failed to
protect patients from abdominal aortic aneurysm–related
death. Additionally, they reported a high rate of late com-
plications, with 49% of the patients having endovascular
leaks and a proximal stent migration rate of 56.5%. These
findings raise the question whether lasting protection from
The Journal of Thoraciprocedure-related death is provided by stent grafts deployed
in the thoracic aorta.
In our series of patients who underwent emergency re-
pair of their lesions of the thoracic aorta, we achieved
superior short-term results with endovascular stent grafts
relative to conventional open surgery, as reported previous-
ly.1 At a mean follow-up of 36.4  12.8 months, however,
the picture had changed somewhat. Actuarial time-related
survival at 4 years was 72.9% in the endovascular group,
compared with 78.6% in the open surgical group (Figure 2).
It is noteworthy that in the surgical group the only death was
due to coexisting disease. In the endovascular group, only 1
of 4 deaths was caused by coexisting disease; the other 3
deaths were related to the treated pathologies of the de-
scending thoracic aorta. Additionally, 9.4% of patients had
late endovascular leaks, requiring reintervention. One of
these patients had paraplegia develop after a second stent
graft was placed to seal a distal endovascular leak, the
second patient required conversion to open surgery, and the
third patient had a rupture of his thoracic aorta. Thus in our
series the incidence of late endovascular leaks was always
associated with severe subsequent complications. Our find-
ings show a trend toward increased procedure-related mor-
tality and morbidity in the endovascular group observable at
4 years. Similar midterm results were reported by other
groups after endovascular stent grafting of acute and elec-
tive lesions of the descending thoracic aorta.
Demers and colleagues15 analyzed a cohort of 103 pa-
tients who underwent endovascular stent-graft repair of the
thoracic aortic aneurysms. Perioperative mortality was 9%,
and overall mortality at 5 years was 51%. They pointed out
that 5-year mortality among good surgical candidates (22%)
was superior to that among patients judged not to be suitable
open surgery candidates (69%). Overall freedom at 5 years
from stent-graft–related complications, including endovas-
cular leaks and aortic intervention, was 56%. Very impor-
tantly, Demers and colleagues15 reported late rupture in 9%
of the patients at 5 years and 20% at 8 years. In our series,
6.2% of patients (n  2) also had late ruptures of thoracic
aortic aneurysms, with evidence of an endovascular leak in
1 case. Orend and associates16 reported their 6-year expe-
rience with 74 patients after endovascular stent-graft repair
for a variety of lesions of the descending thoracic aorta.
Thirty-five percent of the procedures were emergencies.
Overall mortality increased from 9.5% perioperatively to
17.6% at 6 years. In their cohort of patients, only 1 of the 5
late deaths was stent-graft related. The overall rate of en-
dovascular leaks was 20.3%, and 4% of their patients re-
quired conversion to open surgical repair within the fol-
low-up period. An unexpectedly high rate of late
complications after stent-graft placement was also reported
by Resch and coworkers.17 They observed an overall endo-
c and Cardiovascular Surgery ● Volume 129, Number 3 649
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43% of their patients.
The design of our study allowed us to compare directly
the results of patients undergoing emergency endovascular
stent grafting with those of a concurrent control group of
patients undergoing open surgical repair. The comparability
of the two groups was good, because all patients underwent
the same diagnostic and management algorithms and were
treated within the same period for similar lesions. Although
this was not a randomized trial, we still believe that we can
draw valid conclusions from our observations.
Our study showed that the minimally invasive nature of
endovascular interventions improved early outcomes of pa-
tients treated for acute ruptures of the thoracic aorta relative
to the open surgical approach. However, there was a distinct
trend toward increased stent-graft–related mortality and
morbidity at midterm follow-up, suggesting that stent grafts
did not provide lasting protection from late procedure-
related death. In comparison, open surgical graft interposi-
tion resulted in a lasting and stable repair, with no proce-
dure-related deaths occurring at midterm follow up. Late
stent-graft–related complications such as endovascular
leaks and migration necessitating reintervention and con-
version to open surgery remain worrisome and impair post-
operative quality of life.
In conclusion, we believe that the question regarding
long-term complications and durability of stent grafts still
remains unanswered. At midterm follow-up, overall mortal-
ity and morbidity were comparable in stent graft and sur-
gical groups. However, the progressive nature of stent-
graft–related complications stresses the need for continued
surveillance of these patients.
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Discussion
Dr R. Scott Mitchell (Stanford, Calif). Doss and colleagues have
presented a nice series of patients with acutely symptomatic an-
eurysms, dissections, and traumatic transections. They opine that
the favorable early results of endografts may be tempered by late
complications in the endograft group. Although I have several
reservations regarding the comparability of groups (in the article
there is quite a significant age differential of 7 years and probably
twice as many dissections in the stent-graft group), I must say that
those do not mitigate the concerns about the long-term durability
that were emphasized today. There were 4 late deaths in the
stent-graft group, 3 definitely related to the aorta and 1 after
dissection that required subsequent surgical repair. So I think this
emphasizes our continued need for vigilance in these stent grafts,
and I share some of the concerns. I do, however, have several
questions, Dr Doss.
One was partially answered. Did these late endovascular leaks
develop in patients with dissection, with aneurysm, or all of the
above? Second, were any of the late-developing endovascular
leaks related to the 2 early endovascular leaks that you noted at the
time of implantation?
Dr Doss. First, the endovascular leaks occurred in all three
categories. Actually, 1 was in a case of dissection, 1 in a case of
ruptured aortic aneurysm, and 1 in a case of traumatic transection.
Regarding your second question, the early endovascular leaks
that sealed spontaneously were not in the same patients who had
late endovascular leaks. Those actually stayed stable.
Dr Mitchell. I think we now know that, especially in the
diffuse aneurysmal patients, this is a diffuse disease that continues
to progress even if the aneurysm is treated. We have seen the aorta
ch 2005
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what we know now, that you should get as close to that left carotid
as you can and come down as far distal toward the celiac as you
can, is there anything that you could have done differently? Do you
think that these 3 late endovascular leaks, which were catastrophic
failures, might have been prevented?
Dr Doss. I’m afraid I have to say no, because when we looked
at our elective series as well, we also had some late deaths, so these
were just emergency cases presented. But there were also some
late deaths in our elective series and late failure of endografts in
patients who seem to have been very good candidates for endo-
vascular treatment. As you said, the progressive nature of the
aortic disease is a problem that we haven’t really got an answer for
yet.
Dr Mitchell. One late endograft revision resulted in paraplegia.
Had that patient had previous abdominal aneurysm surgery?
Dr Doss. No, he hadn’t. A stent graft was placed and a second
stent graft was placed, but he did not have any aortic aneurysm
The Journal of Thoracisurgery. I know the literature, and I know that has been described,
and we did look at it, but that wasn’t the case.
Dr Mitchell. Finally, this article seems a tactical retreat from
your previously published article, in which your results were quite
supportive of stent-graft repairs. Did the additional 24 months of
follow-up account for this tempering of enthusiasm? What is your
current assessment of this technology and this particular applica-
tion in the patient with acute symptoms?
Dr Doss. Our early published experience did make us en-
thusiastic, and we tried to be very aggressive in treating these
patients with stent grafting, but it is true as you said that within
the last 24 months we saw a rising number of complications in
the emergency group. We also saw a rising number of compli-
cations in the elective group, and it has made us more cautious,
especially in treating patients for whom the indication is not as
clear. Basically, we are trying to look for an optimal patient to
put a stent graft in, rather than trying to treat just any patient
with a stent graft.
c and Cardiovascular Surgery ● Volume 129, Number 3 651
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